Valneva SE EBITDA 2021-2025 | VALN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Valneva SE ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Valneva SE ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$230.9B
Boston Scientific (BSX)	$156.3B
Stryker (SYK)	$149.6B
EssilorLuxottica (ESLOY)	$141.3B
Medtronic (MDT)	$119B
Lonza Group Ag (LZAGY)	$49.8B
Haleon (HLN)	$43.9B
ResMed (RMD)	$40.2B
Agilent Technologies (A)	$35.7B
GE HealthCare Technologies (GEHC)	$33.7B
Terumo (TRUMY)	$26.6B
Koninklijke Philips (PHG)	$26.6B
Insulet (PODD)	$23.9B
Zimmer Biomet Holdings (ZBH)	$21B
Smith & Nephew SNATS (SNN)	$16.4B
Baxter (BAX)	$12.7B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$8.1B
Lantheus Holdings (LNTH)	$3.7B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$3.2B
Haemonetics (HAE)	$2.6B
Acuren (TIC)	$2.3B
Curaleaf Holdings (CURLF)	$2.2B
LeMaitre Vascular (LMAT)	$2.2B
QuidelOrtho (QDEL)	$1.9B